Partial covariance 2D mass spectrometry is the first of its kind and has the potential to revolutionise not only the field of proteomics, but bio-molecular mass spectrometry in general. It is not limited to a specific apparatus (e.g. ion trap or TOF), activation technique (e.g. CID, ECD/ETD, etc.) or biomolecular structure (e.g. peptide, protein, oligonucleotide, etc.)
The 2D MS technology produces spectral signatures that are more specific than 1D MS spectra can be, even at theoretical infinite mass precision and resolution and is well suited for structurally challenging molecules such as isomers. The invention is fully compatible with top-down experiments as shown in Figure 3 by using the pC-2DMS software to extract sequence identities of co-fragmented proteins from a single ‘chimera’ 2D map. The fragment-fragment connectivity data uniquely provided by the pC-2DMS are expected to strongly enhance the capability of de novo sequencing in MS.
1D mass spectrometry (MS) often fails in assigning experimental proteomic MS and tandem MS (MS/MS) data to correct peptide sequences despite its remarkable success in identification and quantification of proteins. Some high biological importance problems, such as identifying mixtures of combinatorially modified peptides, cannot be solved by the state of the art 1D MS.
The partial covariance 2D mass spectrometry (pC-2DMS) for the first time gives access to an entirely new type of structure-specific information: the connectivity between biomolecular fragments detected in tandem MS through covariance correlations between structurally linked pairs. Knowing this connectivity gives a vital advantage for solving the peptide sequence puzzle by piecing the fragments together.
The principle of the covariance 2D mass spectrometry is shown in greater detail in Figure 1, available in the downloadabale datasheet. The 2D MS approach provides direct experimental access to fragment-fragment correlations thereby revealing how these fragments originated, even in the case of very low abundance structural signals.
Using our pC-2DMS analysis software suite, biomolecular sequences are identified by matching the experimentally measured fragment-fragment correlations to ‘theoretical’ pairs of fragments, generated by computer simulation based on protein databases and fragmentation rules. This targeted sequence-specific fragment connectivity strategy can therefore reduce ambiguity in peptide identification dramatically.
- Solves structural problems which cannot be solved by the standard 1D MS as a matter of principle. Demonstrated in Figure 2 (see datasheet)
- Extracts sequence from highly congested spectra of intractable complexity for 1D MS/MS. Demonstrated in Figure 3 (see datasheet)
- Uncovers “hidden” structurally relevant signals that are below the ad hoc intensity thresholds and have to be disregarded in conventional MS.
- Implemented as a software to offer a standalone measurement-to-sequence identification package. Fully compatible with commercial MS instrumentation software.
- Does not require any hardware modifications and can simply be used on a standard mass spectrometer. The technique has been demonstrated using a linear ion trap mass spectrometer.
Intellectual property information
Applied patents: EP3513338A2, US20190206509A1 and GB201803940D0
+44 (0)20 7594 9927